Research programme: therapeutic antibodies - Lexicon Pharmaceuticals/Organon

Drug Profile

Research programme: therapeutic antibodies - Lexicon Pharmaceuticals/Organon

Alternative Names: LG 106

Latest Information Update: 24 Mar 2010

Price : $50

At a glance

  • Originator Lexicon Genetics; Organon
  • Class Antibodies; Proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma; Cancer; Inflammation

Most Recent Events

  • 27 Nov 2008 This programme is still in active development
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 15 May 2007 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top